Phase I study on DMDC

Japanese Journal of Cancer and Chemotherapy

Volumn 23, Issue 13, 1996, Pages 1799-1811

  Gemma, A ^a   Kudoh, S ^a   Fukuoka, M ^a   Kurita, Y ^a   Hasegawa, K ^a   Harada, M ^a   Mori, K ^a   Ariyoshi, Y ^a   Kurihara, M ^a   Furuse, K ^a   Horikoshi, N ^a   Kanamaru, R ^a   Fukuyama, E ^a   Yoneda, S ^a   Furue, H ^a   Taguchi, T ^a   Ota, K ^a   Wakui, A ^a   Tsukagoshi, S ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Ara C derivative; Chemotherapy; DMDC; Phase I study

Indexed keywords

1 (2 DEOXY 2 METHYLENE BETA ERYTHRO PENTAFURASONYL)CYTOSINE DIHYDRATE; CYTOSINE DERIVATIVE; NUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG HALF LIFE; DRUG SAFETY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA;

AGED; ANTINEOPLASTIC AGENTS; COLONIC NEOPLASMS; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 0029859953     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)